Concussion

BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research

Staff August 19, 2025

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...

Oragenics Q2 2025 Shareholder Update

Staff August 11, 2025

Advancing Brain-First Recovery Platform Toward Clinical MilestonesPioneering Intranasal Therapeutics for Concussion SARASOTA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics,...

Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial

Staff July 31, 2025

Strategic CRO Partnership Supports Operational Readiness and Initiation of Upcoming Concussion StudySARASOTA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Oragenics,...

Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development

Staff July 16, 2025

SARASOTA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for...

PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting

Staff July 9, 2025

Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Aviv Clinics Partners with Koterra to Expand Veteran Access to Lifesaving TBI and PTSD Treatment

Staff July 1, 2025

World-renowned brain treatment center is teaming up with a Tampa-based nonprofit to bring hyperbaric oxygen therapy treatments for Veterans across...

Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants

Staff July 1, 2025

SARASOTA, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal...

PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

Staff June 30, 2025

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),...

PreveCeutical Announces Date for Annual General and Special Meeting

Staff June 25, 2025

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients

Staff June 20, 2025

– Research supports combined use of EEG/ERP and vMRI for accurate differential diagnosis of SCD, MCI and dementia – –...

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

Staff June 10, 2025

SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for...

PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor

Staff June 2, 2025

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),...

PreveCeutical Welcomes Stephen Glover as Corporate Advisor

Staff May 26, 2025

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...

PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement

Staff May 22, 2025

Vancouver, British Columbia--(Newsfile Corp. - May 22, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies

Staff May 14, 2025

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a...

Concussion

BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research

Oragenics Q2 2025 Shareholder Update

Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial

Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development

PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting

Aviv Clinics Partners with Koterra to Expand Veteran Access to Lifesaving TBI and PTSD Treatment

Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants

PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

PreveCeutical Announces Date for Annual General and Special Meeting

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor

PreveCeutical Welcomes Stephen Glover as Corporate Advisor

PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement

PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia

PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference

PreveCeutical Announces Up-Sized Non-Brokered Private Placement

Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

HelloNation Article Featuring Eye Care Experts, Dr. R. Krishna Sanka and Dr. Singh, Examines Whether Reducing Glaucoma Eye Drops Can Improve Quality of Life

Study on trauma-informed online learning and GenAI support for student persistence published by University of Phoenix researchers

HelloNation Article Featuring Eye Care Experts, Dr. R. Krishna Sanka and Dr. Singh, Examines Whether Reducing Glaucoma Eye Drops Can Improve Quality of Life

AIAS+ 2026 Brings Leading Scientists to San Francisco to Explore How AI Is Changing Scientific Discovery

Study on trauma-informed online learning and GenAI support for student persistence published by University of Phoenix researchers

You may have missed